Increased [ ¹⁸ F]FDG uptake in the infarcted myocardial area displayed by combined PET/CMR correlates with snRNA-seq-detected inflammatory cell invasion.

Autor: Lukovic D; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Gyöngyösi M; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria. mariann.gyongyosi@meduniwien.ac.at., Pavo IJ; Division of Pediatric Cardiology, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria., Mester-Tonczar J; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Einzinger P; Institute of Information Systems Engineering, Research Unit of Information and Software Engineering, Vienna University of Technology, 1040, Vienna, Austria., Zlabinger K; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Kastner N; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Spannbauer A; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Traxler D; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Pavo N; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Goliasch G; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Pils D; Division of General Surgery, Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria., Jakab A; Center for MR-Research, University Children's Hospital Zurich, Zurich, Switzerland., Szankai Z; Department of Neurology, Kantonsspital Aarau, Aarau, Switzerland., Michel-Behnke I; Division of Pediatric Cardiology, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria., Zhang L; Cardiovascular Research Unit, Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg., Devaux Y; Cardiovascular Research Unit, Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg., Graf S; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Beitzke D; Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria., Winkler J; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.

Publikováno v: Basic research in cardiology [Basic Res Cardiol] 2024 Oct; Vol. 119 (5), pp. 807-829. Date of Electronic Publication: 2024 Jun 26.

Improvement of Symptoms and Cardiac Magnetic Resonance Abnormalities in Patients with Post-Acute Sequelae of SARS-CoV-2 Cardiovascular Syndrome (PASC-CVS) after Guideline-Oriented Therapy.

Autor: Gyöngyösi M; Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria., Hasimbegovic E; Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria., Han E; Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria., Zlabinger K; Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria., Spannbauer A; Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria., Riesenhuber M; Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria., Hamzaraj K; Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria., Bergler-Klein J; Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria., Hengstenberg C; Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria., Kammerlander A; Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria., Kastl S; Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria., Loewe C; Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria., Beitzke D; Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.

Publikováno v: Biomedicines [Biomedicines] 2023 Dec 14; Vol. 11 (12). Date of Electronic Publication: 2023 Dec 14.

Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome.

Autor: Gyöngyösi M; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria. mariann.gyongyosi@meduniwien.ac.at., Lukovic D; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria., Mester-Tonczar J; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria., Zlabinger K; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria., Einzinger P; Institute of Information Systems Engineering, Research Unit of Information and Software Engineering, Vienna University of Technology, 1040, Vienna, Austria., Spannbauer A; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria., Schweiger V; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria., Schefberger K; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria., Samaha E; Department of Internal Medicine I, Klinik Donaustadt, Vienna, Austria., Bergler-Klein J; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria., Riesenhuber M; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria., Nitsche C; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria., Hengstenberg C; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria., Mucher P; Biobank, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Haslacher H; Biobank, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Breuer M; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Strassl R; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Puchhammer-Stöckl E; Center for Virology, Medical University of Vienna, Vienna, Austria., Loewe C; Division of Cardiovascular and Interventional Radiology, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria., Beitzke D; Division of Cardiovascular and Interventional Radiology, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria., Hasimbegovic E; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria., Zelniker TA; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2023 Sep 29; Vol. 8 (1), pp. 145. Date of Electronic Publication: 2023 Sep 29.

Identification of Gene Expression Signatures for Phenotype-Specific Drug Targeting of Cardiac Fibrosis.

Autor: Lukovic D; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria., Hasimbegovic E; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria., Winkler J; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria., Mester-Tonczar J; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria., Müller-Zlabinger K; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria., Han E; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria., Spannbauer A; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria., Traxler-Weidenauer D; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria., Bergler-Klein J; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria., Pavo N; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria., Goliasch G; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria., Batkai S; Hannover Medical School Institute of Molecular and Translational Therapeutic Strategies (IMTTS), 30625 Hannover, Germany., Thum T; Hannover Medical School Institute of Molecular and Translational Therapeutic Strategies (IMTTS), 30625 Hannover, Germany.; Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), 30625 Hannover, Germany., Zannad F; Inserm Clinical Investigation Centre, Université de Lorraine, CHU, 54052 Nancy, France., Gyöngyösi M; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 Apr 18; Vol. 24 (8). Date of Electronic Publication: 2023 Apr 18.

Peri-Interventional Triple Therapy with Dabigatran Modifies Vasomotion after Bare-Metal Stent Implantation in a Pig Coronary Artery Model.

Autor: Hemetsberger R; Department of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria., Farhan S; Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Lukovic D; Department of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria., Zlabinger K; Department of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria., Hajagos-Toth J; Department of Pharmacology and Pharmacotherapy, Albert Szent-Györgyi Medical School, University of Szeged, 6720 Szeged, Hungary., Bota J; Department of Pharmacology and Pharmacotherapy, Albert Szent-Györgyi Medical School, University of Szeged, 6720 Szeged, Hungary., Garcia-Garcia HM; Medstar Hospital Center, Department of Cardiology, Washington, DC 20010, USA., Ay C; Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria., Samaha E; Department of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria., Gaspar R; Department of Pharmacology and Pharmacotherapy, Albert Szent-Györgyi Medical School, University of Szeged, 6720 Szeged, Hungary., Garamvölgyi R; Institute of Diagnostics and Radiation Oncology, University of Kaposvar, 7400 Kaposvar, Hungary., Huber K; 3rd Medical Department with Cardiology, Wilhelminen Hospital, 1160 Vienna, Austria., Spannbauer A; Department of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria., Gyöngyösi M; Department of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, 1090 Vienna, Austria.

Publikováno v: Journal of personalized medicine [J Pers Med] 2023 Jan 31; Vol. 13 (2). Date of Electronic Publication: 2023 Jan 31.